Planning and Evaluation Core

规划与评估核心

• 批准号: 7708673
• 负责人: Gabriel Lopez-Berestein
• 金额: $ 4.29万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-29 至 2013-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7708673
• 关键词: Appendix; Applications Grants; Area; Basic Science; Cancer Center; Clinical; Clinical Cancer Center; Clinical Research; Clinical Trials; Collaborations; Commit; Communities; Community Clinical Oncology Program; Development; Diagnostic; Doctor of Philosophy; Effectiveness; Ensure; Evaluation; Faculty; Fostering; Funding; Goals; Grant; Hospitals; Information Dissemination; Inpatients; Island; Link; Malignant Neoplasms; Manuscripts; Mission; Monitor; National Cancer Program; Outpatients; Patients; Personnel Recruitments; Pharmacologic Substance; Phase; Phase II Clinical Trials; Phase III Clinical Trials; Population; Process; Puerto Rico; Range; Recruitment Activity; Registries; Research; Research Activity; Research Infrastructure; Research Personnel; Research Project Grants; Structure; Students; System; Thinking; Tissues; Training; Training Programs; Training and Education; Translational Research; United States National Institutes of Health; University of Texas M D Anderson Cancer Center; Update; Visit; Work; anticancer research; cancer health disparity; interest; member; outreach; outreach program; programs; symposium; treatment center; tumor; virtual

To sustain the high quality of research expected from this Partnership, strict planning and evaluation processes have been implemented to monitor collaboration building, as well as all projects, programs and cores against both the Partnership's mission, goals and objectives, and the mission, goals and objectives of the U54 mechanism itself, It is our intent to utilize Partnership funding for projects and programs to nurture their development, but not to provide long-term support. As a part of building and sustaining excellence, all projects and programs undergo a strenuous review by our internal and external committees (Table 38) and are expected to (and must develop a plan to) apply for external funding from the NIH or an equivalent agency. These planning and evaluation processes are also instrumental in accurately assessing the Partnership's effectiveness towards achieving its immediate (1-3 years) and intermediate (4-5 years) goals (See Section 1.5) of establishing a sustainable research infrastructure (e.g., key personnel recruitment, clinical accrual cores, tissue cores, assigned building space, and further defining programmatic approaches toward the development of the roadmap to obtain cancer center designation) at the UPRCCC. Not to mention, strategically, a strong ¿ planning and evaluation process is needed to aid the Partnership in achieving its long-term goal (post-U54 funding) of regaining NCI-designation for the UPRCCC. Although regaining NCI-designation is not a direct goal within the scope of the U54 mechanism, as Pis, we believe that it is imperative for us to not just think in terms of U54 specifics, but to pursue goals beyond the U54. For us, regaining NCI-designation is a positive step towards building a stronger national cancer program aimed at understanding the reasons behind cancer health disparities and their impact on the populations we serve.

为了维持该伙伴关系所期望的高质量研究，需要严格的规划和评估流程 已实施以监测协作建设以及所有项目、计划和核心 伙伴关系的使命、目标和目标，以及 U54 的使命、目标和目标 机制本身，我们的目的是利用合作伙伴资助的项目和计划来培养他们 发展，但不提供长期支持 作为建设和维持卓越的一部分，所有项目。 我们的内部和外部委员会对项目进行了严格审查（表 38），并且 预计（并且必须制定计划）向 NIH 或同等机构申请外部资金。 这些规划和评估过程也有助于准确评估伙伴关系的 实现近期（1-3 年）和中期（4-5 年）目标的有效性（参见第 1.5 节） 建立可持续的研究基础设施（例如，关键人员招聘、临床应计核心、 组织核心、分配的建筑空间，以及进一步定义开发的规划方法 UPRCCC 的癌症中心指定路线图）。 ¿需要规划和评估流程来帮助伙伴关系实现其长期目标（后 U54 资金）重新获得 UPRCCC 的 NCI 指定。 在 U54 机制范围内的目标，作为 Pis，我们认为我们的当务之急不仅仅是 考虑 U54 的具体情况，但要追求超越 U54 的目标，重新获得 NCI 称号。 是朝着建立更强大的国家癌症计划迈出的积极一步，旨在了解 癌症健康差异背后的原因及其对我们服务的人群的影响。